Veterinary Medicines

ATONYL 1.5 mg/ml SOLUTION FOR INJECTION

Authorised
  • NEOSTIGMINE METHYLSULFATE
Download as PDF

Product identification

Medicine name:
ATONYL 1.5 mg/ml SOLUTION FOR INJECTION
ATONYL 1,5 mg/ml, injekcinis tirpalas
Active substance:
  • NEOSTIGMINE METHYLSULFATE
Target species:
  • Cattle
  • Sheep
  • Goat
  • Horse
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • NEOSTIGMINE METHYLSULFATE
    1.50
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
    • Sheep
    • Goat
    • Horse
  • Subcutaneous use
    • Cattle
    • Sheep
    • Goat
    • Horse
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN07AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:
  • cardboard box containing 1 vial of 40 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Cenavisa S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cenavisa S.L.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/19/2567/001
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0341/001
Concerned member states:
  • Bulgaria
  • Hungary
  • Latvia
  • Lithuania
  • Portugal
  • Romania

Documents

Summary of Product Characteristics

English (PDF)
Published on: 12/04/2023
Download

Package Leaflet

English (PDF)
Published on: 12/04/2023
Download

Labelling

English (PDF)
Published on: 12/04/2023
Download

RV2567.pdf

Lithuanian (PDF)
Published on: 6/03/2024
Download

eu-PUAR-atonyl-1.5-mg-ml-solution-for-injection-en.pdf

English (PDF)
Published on: 12/04/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."